Abstract
The venture arms of Pfizer and Roche have led a $43 million round of financing for Second Genome, which is developing small molecules that modulate the microbiome. Second Genome plans to use the ca...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have